Completely agree with you. My point is what is our strategy for resisting the introduction of treatments which at best may be low value, at worse cause actual harm? I think that is an issue for all of us to influence.
-
-
This Tweet is unavailable.
-
- Show replies
-
-
-
This may help you: Charging rules for
#ExpandedAccess in the U.S. is limited to direct cost; i.e. no profit margin. RTT copied that requirement. (2) It is not evidence-based reimbursement, it is the price of the IP with which a doctor and patient may explore treatment use.Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
RTT isn't itself the demise of evidence based medicine. But I fear it's the first step in a long road toward that end.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
How would you tell the difference?
-
If there is a demise of EBM?
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.